moxifloxacin has been researched along with Cerebromeningitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, R; Hu, Y; Huang, Y; Liu, C; Liu, H; Long, J; Wang, Q; Xie, H; Xing, L; Yan, Z; Zheng, W | 1 |
| Jaeger, B; Pajkrt, D; Said, I; van de Beek, D; van Hest, RM; Wildenbeest, JG | 1 |
1 review(s) available for moxifloxacin and Cerebromeningitis
| Article | Year |
|---|---|
Neonate with Mycoplasma hominis meningoencephalitis given moxifloxacin.
Topics: Acyclovir; Amoxicillin; Anti-Bacterial Agents; Antiviral Agents; Cefotaxime; Cerebrospinal Fluid; Female; Fever; Fluoroquinolones; Humans; Infant, Newborn; Meningoencephalitis; Moxifloxacin; Mycoplasma hominis; Polymerase Chain Reaction | 2016 |
1 other study(ies) available for moxifloxacin and Cerebromeningitis
| Article | Year |
|---|---|
Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Doxycycline; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Meningoencephalitis; Moxifloxacin; Seafood; Seawater; Sepsis; Splenectomy; Thalassemia; Treatment Outcome; Vibrio vulnificus | 2019 |